BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22877238)

  • 1. A simple and inexpensive haemozoin-based colorimetric method to evaluate anti-malarial drug activity.
    Men TT; Huy NT; Trang DT; Shuaibu MN; Hirayama K; Kamei K
    Malar J; 2012 Aug; 11():272. PubMed ID: 22877238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing anti-malarial drug effects ex vivo using the haemozoin detection assay.
    Rebelo M; Tempera C; Fernandes JF; Grobusch MP; Hänscheid T
    Malar J; 2015 Apr; 14():140. PubMed ID: 25879757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying rapidly parasiticidal anti-malarial drugs using a simple and reliable in vitro parasite viability fast assay.
    Linares M; Viera S; Crespo B; Franco V; Gómez-Lorenzo MG; Jiménez-Díaz MB; Angulo-Barturen Í; Sanz LM; Gamo FJ
    Malar J; 2015 Nov; 14():441. PubMed ID: 26542470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between anti-malarial and anti-haemozoin activities of anti-malarial compounds.
    Tam DNH; Tawfik GM; El-Qushayri AE; Mehyar GM; Istanbuly S; Karimzadeh S; Tu VL; Tiwari R; Van Dat T; Nguyen PTV; Hirayama K; Huy NT
    Malar J; 2020 Aug; 19(1):298. PubMed ID: 32825818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro anti-malarial efficacy of chalcones: cytotoxicity profile, mechanism of action and their effect on erythrocytes.
    Sinha S; Batovska DI; Medhi B; Radotra BD; Bhalla A; Markova N; Sehgal R
    Malar J; 2019 Dec; 18(1):421. PubMed ID: 31842914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lapatinib, Nilotinib and Lomitapide Inhibit Haemozoin Formation in Malaria Parasites.
    de Sousa ACC; Maepa K; Combrinck JM; Egan TJ
    Molecules; 2020 Mar; 25(7):. PubMed ID: 32235391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro susceptibility of P. falciparum isolates from Abidjan (Côte d'Ivoire) to quinine, artesunate and chloroquine].
    Touré AO; Koné LP; Jambou R; Konan TD; Demba S; Beugre GE; Koné M
    Sante; 2008; 18(1):43-7. PubMed ID: 18684691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplasmodial activity, in vivo pharmacokinetics and anti-malarial efficacy evaluation of hydroxypyridinone hybrids in a mouse model.
    Dambuza NS; Smith P; Evans A; Norman J; Taylor D; Andayi A; Egan T; Chibale K; Wiesner L
    Malar J; 2015 Dec; 14():505. PubMed ID: 26671222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemolysis of Plasmodium falciparum trophozoite-infected erythrocytes after artemisinin exposure.
    Orjih AU
    Br J Haematol; 1996 Feb; 92(2):324-8. PubMed ID: 8602993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is haemozoin a target for antimalarial drugs?
    Meshnick SR
    Ann Trop Med Parasitol; 1996 Aug; 90(4):367-72. PubMed ID: 8944080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of mimicking febrile temperature and drug stress on malarial development.
    Aunpad R; Somsri S; Na-Bangchang K; Udomsangpetch R; Mungthin M; Adisakwattana P; Chaijaroenkul W
    Ann Clin Microbiol Antimicrob; 2009 Jun; 8():19. PubMed ID: 19523215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of a multi-well colorimetric assay to determine haem species in Plasmodium falciparum in the presence of anti-malarials.
    Combrinck JM; Fong KY; Gibhard L; Smith PJ; Wright DW; Egan TJ
    Malar J; 2015 Jun; 14():253. PubMed ID: 26099266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantum dots: a new tool for anti-malarial drug assays.
    Ku MJ; Dossin FM; Choi Y; Moraes CB; Ryu J; Song R; Freitas-Junior LH
    Malar J; 2011 May; 10():118. PubMed ID: 21554712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemozoin detection in infected erythrocytes for Plasmodium falciparum malaria diagnosis-prospects and limitations.
    Rebelo M; Shapiro HM; Amaral T; Melo-Cristino J; Hänscheid T
    Acta Trop; 2012 Jul; 123(1):58-61. PubMed ID: 22465900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulating effects of plasma containing anti-malarial antibodies on in vitro anti-malarial drug susceptibility in Plasmodium falciparum.
    Monatrakul P; Mungthin M; Dondorp AM; Krudsood S; Udomsangpetch R; Wilairatana P; White NJ; Chotivanich K
    Malar J; 2010 Nov; 9():326. PubMed ID: 21078202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemoglobin interference and increased sensitivity of fluorimetric assays for quantification of low-parasitaemia Plasmodium infected erythrocytes.
    Moneriz C; Marín-García P; Bautista JM; Diez A; Puyet A
    Malar J; 2009 Dec; 8():279. PubMed ID: 19961586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resonance Raman spectroscopy can detect structural changes in haemozoin (malaria pigment) following incubation with chloroquine in infected erythrocytes.
    Webster GT; Tilley L; Deed S; McNaughton D; Wood BR
    FEBS Lett; 2008 Apr; 582(7):1087-92. PubMed ID: 18325340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrophotometric detection of susceptibility to anti-malarial drugs.
    Serebrennikova YM; Patel J; Milhous WK; Garcia-Rubio LH; Huffman DE; Smith JM
    Malar J; 2013 Aug; 12():305. PubMed ID: 23992478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards a needle-free diagnosis of malaria: in vivo identification and classification of red and white blood cells containing haemozoin.
    Burnett JL; Carns JL; Richards-Kortum R
    Malar J; 2017 Nov; 16(1):447. PubMed ID: 29115957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limitations of haemozoin-based diagnosis of Plasmodium falciparum using dark-field microscopy.
    Delahunt C; Horning MP; Wilson BK; Proctor JL; Hegg MC
    Malar J; 2014 Apr; 13():147. PubMed ID: 24739286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.